Register Login
Register to leave comments
  • News bot Sept. 1, 2026, 12:16 a.m.

    🔍 Sayad Pierre Sargis (Executive)

    Company: FENNEC PHARMACEUTICALS INC. (FENC)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 168
    • Total shares sold: 12,000

    Detailed Transactions and Holdings:

    • Acquired 168 shares of Common Shares (Direct)
      Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 21,519.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 12,000 shares of Common Shares at $12.18 per share (Direct)
      Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,519.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents shares released from restriction from shares awarded 3/28/2025.
    • F2: Represents sale of previously vested restricted shares and vested performance shares.

Search

News categories